Belly chemo for colorectal cancer spread
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial tests giving two chemotherapy drugs (oxaliplatin and fluorouracil) directly into the belly for people whose colorectal cancer has spread only to the lining of the belly. The goal is to see if this approach can help control the cancer in the abdomen.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older.
- Your colorectal cancer must have spread only to the lining of your belly (peritoneum), not to other organs like the liver or lungs.
- You cannot have already had a type of surgery called 'cytoreductive surgery with HIPEC' for your colorectal cancer.
- You need to be able to walk and do light work (ECOG 0 or 1).
- You must be willing to have two small laparoscopies (belly inspections) with tissue samples taken.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to give chemotherapy by spraying it into the belly during a minimally invasive surgery. It is for people whose colon or rectal cancer has spread inside the belly (peritoneal metastasis) but not to other organs.
This trial tests a combination of heated chemotherapy given directly into the belly (HIPEC), standard chemotherapy (SOX), and an immunotherapy drug (sintilimab) for people with advanced stomach cancer that has spread to the lining of the abdomen. The goal is to see if this triple therapy can shrink or control the cancer better than standard treatments.
This trial tests a combination of three chemotherapy drugs (liposomal irinotecan, oxaliplatin, and capecitabine) given directly into the liver blood vessel after surgery to remove colorectal cancer that has spread to the liver. The goal is to reduce the chance of cancer coming back.
This trial tests a new cell therapy (CAR-NK cells given directly into your belly and a vein) combined with a targeted drug (cetuximab) for colorectal cancer that has spread mainly to the lining of your belly. It aims to see if this treatment can shrink tumors and help people who have run out of standard chemotherapy options.
This trial tests putting a chemo drug (fluorouracil) directly into the colon through a tube. It's for people with colorectal cancer who are already getting other cancer treatment, to see if adding local chemo helps shrink the main tumor.
This trial tests a combination of low-dose radiation therapy, immunotherapy, and chemotherapy for people whose stomach or colon cancer has spread to the lining of the belly (peritoneal cavity). The goal is to see if this approach can help control the cancer.
Hear when a new Metastatic Colorectal Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.